Bone Biologics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$1.38

-0.02 (-1.43%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,435.5% upside

Low Target $14.35

Average Target $21.19

High Target $22.63

Current Price $1.38

Current
$1.38

Target
$21.19

$14.35 $21.19 avg $22.63

Scenario Analysis

Bear Case

$14.35

939.9%

Low target

Base Case

$21.19

+1,435.5%

Avg target

Bull Case

$22.63

+1,539.9%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$6.19

-77.7% from high

52-Week Low

$1.05

+31.4% from low

Target vs 52W High

$21.19

+242.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%